{ }
001122334455554433221100
001122334455554433221100

pharmaceutical industry updates on mergers recalls and new drug developments

Verdiva Bio has launched with a $410 million series A to develop weight loss drugs, including a weekly oral GLP-1 agonist. Roche's Chugai has partnered with Araris Biotech for a deal potentially worth over $780 million to create multi-payload antibody-drug conjugates. Meanwhile, Astellas has halted its early-stage lymphoma CAR-T therapy following a pipeline review, and Merck has acquired a vaccine plant in Ireland from WuXi Biologics for €500 million.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.